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Summary
Cerebral palsy has an incidence of ∼1/500 births, al-
though this varies between different ethnic groups. Ge-
netic forms of the disease account for ∼1%–2% of cases
in most countries but contribute a larger proportion in
populations with extensive inbreeding. We have clini-
cally characterized consanguineous families with mul-
tiple children affected by symmetrical spastic cerebral
palsy, to locate recessive genes responsible for this con-
dition. The eight families studied were identified from
databases of patients in different regions of the United
Kingdom. After ascertainment and clinical assessment,
we performed a genomewide search for linkage, using
290 polymorphic DNA markers. In three families, a re-
gion of homozygosity at chromosome 2q24-q25 was
identified between the markers D2S124 and D2S148.
The largest family gave a maximum LOD score of 3.0,
by multipoint analysis (HOMOZ). The maximum com-
bined multipoint LOD score for the three families was
5.75. The minimum region of homozygosity is ∼5 cM
between the markers D2S124 and D2S2284. We have
shown that a proportion of autosomal recessive sym-
metrical spastic cerebral palsy maps to chromosome
2q24-25. The identification of genes involved in the
etiology of cerebral palsy may lead to improved man-
agement of this clinically intractable condition.
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Introduction
Cerebral palsy is a common disorder of childhood, with
an incidence of 1/250–1/1,000 births (Pharoah et al.
1987; Bundey and Alam 1993). It is defined as a non-
progressive but not unchanging disorder of posture or
movement, caused by an abnormality of the brain and
first evident at the stage of rapid brain development
(Hughes and Newton 1992). Cerebral palsy can be clas-
sified according to the specific type of movement dis-
order observed (Hagberg et al. 1972). Spastic cerebral
palsy accounts for ∼60% of cases and is subdivided into
hemiplegia, diplegia, quadriplegia, and monoplegia.
Other types of movement disorder seen in cerebral palsy
are athetoid/dyskinetic, ataxic, and mixed. The athetoid/
dyskinetic and ataxic groups each account for 5%–10%
of the condition overall, with the mixed group consti-
tuting the remainder (Gustavson et al. 1969).
Recent studies have documented that only 10%–15%
of cases of cerebral palsy can be attributed to intrapar-
tum problems (Blair and Stanley 1988). The other major
risk factors are now recognized to be prematurity, small
size for gestational age, and multiple pregnancy (Stanley
1994). The majority of children with cerebral palsy born
at 136 wk gestation have no recognized birth asphyxia,
and only ∼40% have a possible potential cause (Hagberg
and Hagberg 1993).
It is among the 60% of idiopathic cases that the rarer
genetic forms of cerebral palsy occur. Approximately 2%
of all cases of cerebral palsy in Swedish and English
children are due to a genetic cause (Gustavson et al.
1969; Bundey and Griffiths 1977). Most of these cases
have no recognizable adverse pre- or postpartum events
and have marked symmetry of the neurological signs.
Thus it follows that hemiplegia and monoplegia are
rarely, if ever, genetic. Ataxic cerebral palsy occurring
without an obvious predisposing event is likely to be
genetic in approximately half the cases, and the same is
true for idiopathic athetoid cerebral palsy (Hughes and
Newton 1992).
Spastic cerebral palsy is the most common subtype
and has a low overall recurrence risk. Spastic cerebral
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Table 1





at 2q24-25? Mental Retardation Epilepsy Microcephaly
3 Yes Moderate Absent Absent Diplegia
4 Yes Moderate and severe Absent Variable Diplegia
8 Yes Severe Present Present Quadriplegia
1 No Moderate and severe Present Variable Diplegia
2 No Moderate Absent Absent Diplegia
5 No Moderate Absent Absent Diplegia
6 No Severe Absent Present Quadriplegia
7 No Severe Present Variable Quadriplegia
palsy that is both symmetrical and idiopathic accounts
for !4% of all cerebral palsy cases, but its recurrence
risk in sibs is ∼1/8 (Bundey and Griffiths 1977). Most
cases are autosomal recessive, but rare autosomal dom-
inant and X-linked forms have also been described (Bun-
dey and Griffiths 1977; Bundey et al. 1978). There are
no previous reports of genetic linkage for autosomal
recessive “true” spastic cerebral palsy.
We have used homozygosity mapping to identify ge-
netic loci involved in spastic cerebral palsy in eight con-
sanguineous families originating from the Mirpur region
of Pakistan (Mitchell and Bundey 1997). The affected
children have a symmetrical, nonprogressive spasticity
and no adverse perinatal history or obvious underlying
alternative diagnosis. Careful documentation of the clin-
ical phenotype was undertaken. A genomewide search
was performed to identify a genetic locus that cosegre-
gated with spastic cerebral palsy in these families.
Subjects and Methods
Study Families and Diagnosis
The probands from the seven families were ascer-
tained from the database of patients of the West Mid-
lands Paediatric Neurology and Clinical Genetics Service
(United Kingdom) and from the records of local special
schools and child-development centers within the city of
Birmingham (Mitchell and Bundey 1997). One further
family was ascertained by the Yorkshire Regional Clin-
ical Genetics Service, Leeds. The following criteria were
used: (1) Pakistani ethnic origin, (2) nonprogressive sym-
metrical spasticity, and (3) no identifiable perinatal cause
or known alternative underlying diagnosis.
The numbering of these families corresponds to that
used in Mitchell and Bundey’s (1997) paper describing
the clinical phenotypes. The clinical features of the fam-
ilies are summarized in table 1. The case histories of the
linked families are detailed below, to highlight clinical
differences between them, as well as the minor pheno-
typic variability that occurs even between siblings.
Family 3.—The oldest affected boy was born in Feb-
ruary 1981 in Pakistan and came to the United Kingdom
at the age of 3 years. At that time, he had global de-
velopmental delay and was neither walking nor speak-
ing. He attended a day school for children with mod-
erate-to-severe learning difficulties. When seen, he was
a friendly but moderately retarded boy with little ca-
pacity for speech. His head circumference was at the
10th centile, and there were no abnormalities of either
the cranial nerves or the upper limbs. He had a sym-
metrical spastic diplegia with brisk leg reflexes and
equivocal plantar responses, but he was able to walk.
There was no evidence of either a neuropathy or an
ataxia.
The proband’s sister was born in the United Kingdom
in July 1986. She also presented with global develop-
mental delay. She could walk with support at age 3 years
and without support at age 5–6 years. Her speech was
markedly delayed and remains poor. When examined at
age 8 years, she was friendly, moderately mentally re-
tarded, and walking. Neurological examination revealed
increased tone in her legs, brisk tendon reflexes, and
equivocal plantar responses. There was no abnormality
of her cranial nerves, and she had neither ataxia nor
spasticity in her arms.
Family 4.—All the children were born in the United
Kingdom and had no pre- or perinatal problems. The
oldest affected girl had bilateral dislocated hips that re-
quired surgical correction. She never walked indepen-
dently and has been in a wheelchair since the age of 4
years. She is severely mentally retarded.
When reviewed at age 14 years, she still had not de-
veloped bladder or bowel control. Examination revealed
a severely retarded child with no recognizable speech.
Her head circumference was at the 25th–50th centile.
She had a marked spastic diplegia with increased tone,
contractures at the knees, brisk reflexes, and extensor
plantar responses. There was no nystagmus, and no cra-
nial nerve abnormality was observed.
Her 12-year-old brother is also severely retarded, with
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Table 2
Frequency of Disease-Associated Alleles in Each Family
MARKER
DISEASE ALLELE (FREQUENCY) IN
Family 3 Family 4 Family 5
D2S142 Heterozygous Heterozygous 123 (.20)
D2S124 159 (.29) Heterozygous 159 (.29)
D2S2345 156 (.20) 152 (.34) 156 (.20)
D2S376 269 (.62) 267 (.16) 269 (.62)
D2S2284 Heterozygous 165 (.18) 165 (.18)
D2S333 Heterozygous 203 (.21) 199 (.53)
D2S2302 Heterozygous 189 (.07) 187 (.32)
D2S326 Heterozygous 89 (.06) 89 (.06)
D2S2188 Heterozygous 137 (.18) 139 (.04)
D2S148 Heterozygous 187 (.42) 187 (.42)
D2S300 Heterozygous Heterozygous Heterozygous
limited speech, and he too has not attained bladder or
bowel control. On examination, his head circumference
was !3d centile, and he had a kyphoscoliosis, a spastic
diplegia with flexion contractures at the knees and ex-
tension contractures at the hips. There was symmetrical
wasting of both lower limbs, with brisk tendon reflexes
and equivocal plantar responses. Mild hypertonia and
ataxia of the upper limbs were noted. No abnormality
of the cranial nerves was present.
The next affected boy was one of DZ twins born by
cesarean section. He presented with developmental de-
lay, and, when reviewed at the age of 9 years, he was
crawling and had symmetrical spasticity of his legs, with
brisk reflexes and upgoing plantar responses. There was
mild hypertonia of the arms, with some ataxia. He was
dysarthric but had no nystagmus, and there was no ab-
normality of the cranial nerves.
A younger sister, when examined at age 19 mo, was
able to neither walk nor stand. Her head circumference
was at the 25th centile. There was neither nystagmus
nor abnormalities of her cranial nerves or arms. The
tendon reflexes in her legs were pathologically brisk, and
her plantar responses were extensor.
Family 8.—This family of Pakistani origin has been
ascertained recently in a U.K. region geographically sep-
arate from that of the other seven families. The second
and fourth sons of first-cousin parents were born in the
United Kingdom and were found to be microcephalic,
with head circumferences 13 SD below the mean. The
pregnancies and deliveries for both boys were unevent-
ful. Hypotonia was present during the 1st year of life,
but, by age 3 years, quadriplegic spasticity and severe
developmental delay were apparent in both boys. Sei-
zures developed in them both at age 6 mo, and grand
mal fits have occurred approximately monthly since
then. Neither child is dysmorphic or has any features
suggestive of a metabolic disorder. Review of the older
boy at age 16 years revealed that he has gross contrac-
tures, communicates only by grunting, and has a head
circumference of 46.5 cm (6 cm below the 3d centile).
The affected 4-year-old has severe spasticity, achilles-
tendon and knee contractures, a head circumference of
43 cm (6 cm below the 3d centile), and no speech.
Genomewide Search
The markers used for the genomewide search were
originally described by Reed et al. (1994) and have an
average spacing of one marker every 12–14 cM. Extra
markers mapping to regions of possible homozygosity
were identified from the CEPH-Ge´ne´thon Integrated
Map. PCR products were labeled either by incorporation
of 5′–fluorescently labeled oligonucleotide primers or by
the addition of FAM-labeled dUTP to the reaction. Anal-
ysis of the PCR products was performed by an auto-
mated ABI 377 Gene Scanner.
PCR was performed in a total volume of 20 ml con-
taining 40 ng of DNA, 0.2 mM of each dNTP, 1.5 mM
MgCl2, 50 ng of each primer, 1 unit of Taq DNA poly-
merase, 50 mM KCl, 10 mM Tris-HCl (pH 9.0), and
1% Triton X-100. Annealing temperatures were opti-
mized for each primer pair. PCR cycles were as follows:
95C for 5 min, followed by 30 cycles of 95C for 20
s, annealing temperature at 20 s, and 72C for 20 s, with
a final extension at 72C for 5 min. If the primers were
not fluorescently labeled, then 0.02 ml of 100 mM FAM-
labeled dUTP was added to each reaction. PCR products
were analyzed on a 4% polyacrylamide/6 M urea/
EDTA gel for 2 h at 3,000 V and at a1# Tris-borate
fixed temperature of 51C. The data were captured by
the ABI Genescan software package, and genotypes were
generated by the Genotyper software package (Applied
Biosystems).
Statistical Analysis
Linkage analysis was performed by both LIPED, for
two-point analysis (Ott 1976), and HOMOZ/MAP-
MAKER, for multipoint analysis (Kruglyak et al. 1995).
The allele frequencies for each polymorphic marker were
estimated on the basis of values in 35 unrelated control
individuals originating from the same region of Pakistan
as the families involved in the study. The frequency of
the allele for each marker associated with the disease is
shown, for each family, in table 2. A disease-allele fre-
quency of 1/200 was used. All the families were geno-
typed with the markers identified within the region of
interest. The results for the three families with homo-
zygous-by-descent regions were then combined (fig. 1).
Results
Phenotypes
Table 1 shows the main clinical features seen within
each of the families. The families have been classified
according to whether they have a region of homozy-
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Figure 1 Multipoint analysis of family 4 and combined result for all three linked families. Map distances are from the Genome Database.
gosity 5 cM on chromosome 2q24-25. Although con-
siderable inter- and intrafamilial variability was seen,
there were no clinical features that could have been used
to distinguish families segregating with this region of
chromosome 2 versus those families showing no evi-
dence of linkage.
Genotypes
Seven of the eight families were typed with 290 mark-
ers evenly spaced across the genome. All the affected
members of family 4 were homozygous for the same
allele at the marker D2S326. This generated a two-point
LOD score of 2.6, by LIPED. Further markers
(cen–D2S142, D2S124, D2S2345, D2S376, D2S2284,
D2S333, D2S2302, D2S2188, D2S148, D2S300–tel)
from this region were identified from the CEPH-Ge´ne´-
thon Integrated Map map. Multipoint analysis was per-
formed by the HOMOZ/MAPMAKER computer pro-
gram; the results are shown in figure 1.
The marker D2S326 was the only marker in the ge-
nomewide search that was fully informative and ho-
mozygous in all four affected children from family 4.
Haplotype analysis ruled out other potential homozy-
gosity-by-descent regions from the initial screen.
All the families were genotyped with the marker
D2S326 and with the additional markers from the region
of interest. The LOD scores from the multipoint analyses
of the families with regions of homozygosity 15 cM were
combined and are shown in figure 1. The genotypes are
shown in figure 2.
Discussion
The results of the genomewide search revealed that all
four affected individuals from family 4 were homozy-
gous for the marker D2S326. Additional markers from
this region of chromosome 2q24-25 (D2S142, D2S124,
D2S2345, D2S376, D2S2284, D2S333, D2S2302,
D2S2188, D2S148, and D2S300) were selected at spac-
ings of ∼2 cM. These identified a 12-cM interval of
homozygosity, flanking D2S326 between the markers
D2S124 and D2S300. Multipoint analysis was per-
formed on the results for this family, by HOMOZ/MAP-
MAKER (Kruglyak et al. 1995), and a maximum LOD
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Figure 2 Genotype data for families with linkage to chromosome 2q24-25. The allele sizes of the respective microsatellite markers used
are indicated, in chromosomal order, beneath genotyped individuals
score of 3.0, between the markers D2S2345 and
D2S300, was generated (fig. 1).
The remaining seven families that we had character-
ized were then genotyped with the marker set from the
critical region. A region of homozygosity 5 cM was
also present in two of these families (families 3 and 8).
The combined, multipoint-analysis result from the initial
family and these two other families gave a maximum
LOD score of 5.75, between the markers D2S124 and
D2S2284 (fig. 1). All affected individuals from these
three linked pedigrees have a region of homozygosity of
∼5 cM, between the markers D2S124 and D2S2284 (fig.
2). In the remaining five families, the LOD scores ranged
from negative infinity to .5, but in no one family was a
LOD score of2 observed across the whole region. This
was due to both the small size of the families, with all
except one having only two affected members, and the
fact that some of the markers were only partially infor-
mative, resulting in homozygous markers but no definite
region of homozygosity. Formal analysis with HOMOG
led to equivocal results for each of these five families.
No haplotype common to the three pedigrees was ob-
served. The families used in the study all originate from
the Mirpur region of Pakistan. It is possible that these
families are distantly related, potentially allowing the use
of linkage-disequilibrium mapping to define a smaller
candidate region, by use of a higher density of poly-
morphic markers. Ascertainment of additional linked
families may also allow the narrowing of the common
region of homozygosity, prior to both physical mapping
of the region and candidate-gene analysis.
There are 59 cDNA transcripts reported to map to
the region, according to the Genome Maps 96 database.
Of these, there are two known genes that would make
plausible candidates. The first is a brain-specific voltage-
gated sodium channel. The Drosophila homologue of
this gene is called “paralytic,” and mutations result in
abnormal—or, in some cases, no—conduction within
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parts of the CNS. A second candidate gene is GAD1,
which codes for a 67-kD isoform of glutamate decar-
boxylase. This enzyme is involved in the production of
gamma-aminobutyric acid (GABA), which is a potent
inhibitory neurotransmitter. Many of the remaining
cDNA species are expressed in neural tissue and would
therefore be positional candidates for the gene that
causes symmetrical spastic cerebral palsy.
Genetic forms of spastic cerebral palsy usually present
with symmetrical neurological signs and no other ob-
vious potential cause (Mitchell and Bundey 1997). Sev-
eral other variable features are seen, including mental
retardation, microcephaly, and epilepsy. Despite careful
clinical assessment, there was no consistent overall dis-
ease phenotype segregating in the families with linkage
to chromosome 2q24-25, compared with the unlinked
families. In addition, considerable inter- and intra-
familial variation was seen, consistent with complex
and interactions.gene# environment gene# gene
Thus, clinical assessment alone is not sufficient to dis-
tinguish between the group of children suffering from
inherited spastic cerebral palsy caused by mutations in
a gene mapping to chromosome 2q24-25 versus those
children in whom the mutations are at another locus.
The gene(s) involved in the etiology of inherited spas-
tic cerebral palsy will presumably encode an important
group of human CNS developmental proteins that, al-
though necessary both for early neural development and
to establish cerebral function, do not necessarily cause
worsening problems if absent during childhood and later
life. This suggests that these genes may prove to have
temporal- or site-specific expression patterns within the
developing brain and may only be essential during the
relatively early stages of growth of the immature CNS.
It also seems likely that a proportion of sporadic cases
of spastic cerebral palsy may be attributable to environ-
mental factors that have an impact on the expression of
these genes in utero. Cloning of these genes may provide
unique insights into the mechanisms involved in the dif-
ferentiation of neuronal pathways and, in particular,
those factors involved in motor function. Greater un-
derstanding of the early developmental mechanisms in
these neural networks during fetal life may lead to the
possibility of coordinated regeneration of damaged tis-
sue, in an attempt to improve function in a variety of
conditions involving neuronal damage.
Cerebral palsy is a common, poorly understood, and
intractable group of conditions seen by pediatricians,
family practitioners, neurologists, and general physi-
cians, since many of these children survive into adult-
hood. Although genetic forms of this condition account
for only 1%–2% of all cases, they offer a unique insight
into both the causes of the disease and the development
of specific neuronal pathways. Elucidation of these path-
ways will undoubtedly improve our understanding of
the pathophysiology of cerebral palsy.
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